AquaBounty Technologies (NASDAQ:AQB) Trading 3.1% Higher

AquaBounty Technologies, Inc. (NASDAQ:AQBGet Free Report) shares shot up 3.1% on Monday . The stock traded as high as $1.67 and last traded at $1.66. 18,292 shares traded hands during mid-day trading, a decline of 24% from the average session volume of 23,926 shares. The stock had previously closed at $1.61.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently commented on AQB shares. Oppenheimer reiterated a “market perform” rating on shares of AquaBounty Technologies in a research report on Tuesday, April 2nd. HC Wainwright reiterated a “neutral” rating on shares of AquaBounty Technologies in a research report on Thursday, May 16th.

Check Out Our Latest Stock Analysis on AquaBounty Technologies

AquaBounty Technologies Stock Performance

The company has a debt-to-equity ratio of 0.03, a current ratio of 0.26 and a quick ratio of 0.23. The business’s 50-day moving average is $1.82 and its 200 day moving average is $2.10. The firm has a market capitalization of $6.14 million, a P/E ratio of -0.19 and a beta of 1.18.

AquaBounty Technologies (NASDAQ:AQBGet Free Report) last posted its quarterly earnings data on Wednesday, May 15th. The company reported ($1.53) EPS for the quarter, missing analysts’ consensus estimates of ($1.42) by ($0.11). The company had revenue of $0.48 million for the quarter, compared to the consensus estimate of $0.50 million. AquaBounty Technologies had a negative return on equity of 16.07% and a negative net margin of 1,263.43%. As a group, analysts anticipate that AquaBounty Technologies, Inc. will post -4.86 EPS for the current fiscal year.

AquaBounty Technologies Company Profile

(Get Free Report)

AquaBounty Technologies, Inc, a biotechnology company, operates in the aquaculture industry in the United States and Canada. The company engages in genetic, genomic, and fish health and nutrition research activities. It also operates salmon farms using proprietary technology. In addition, the company offers AquAdvantage Salmon, a genetically engineered Atlantic salmon for human consumption; and sells conventional Atlantic salmon, salmon eggs, fry, and byproducts.

Featured Articles

Receive News & Ratings for AquaBounty Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AquaBounty Technologies and related companies with MarketBeat.com's FREE daily email newsletter.